Dicerna Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -7.08 | -100% |
| P/S |
|
15.2 | 33.76 | -54.97% |
|
|
| P/BV |
|
27.7 | 4.82 | 474.6% |
|
|
| P/FCF |
|
331.11 | 61 | 442.8% |
|
|
| Ev/Ebitda |
|
-20.9 | -22.15 | -5.65% |
|
|
| Ev/S |
|
12.85 | 22.56 | -43.05% |
|
|
| Ev/FCF |
|
275.56 | 68.78 | 300.66% |
|
|
| E/P |
|
-0.0416 | 0.0178 | -334.05% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-62.88 | 4.98 | -1363.43% | -929.35 | -93.23% |
| ROE |
|
-95.22 | 9.61 | -1090.68% |
|
|
| ROA |
|
-17.12 | 0.3443 | -5072.99% |
|
|
| ROIC |
|
-72.29 | 7.63 | -1046.9% |
|
|
| ROS |
|
-64.25 | -25.17 | 155.26% |
|
|
| ROCE |
|
0 | 15.35 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.5518 | -3.68 | -84.99% | -0.4633 | +19.11% |
| Nеt Debt/Ebitda |
|
0 | -3.44 | -100% |
|
|
| Debt/Ratio |
|
0.091 | 0.1985 | -54.16% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
-0.5194 | 10.32 | -105.03% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5468 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.2632 | -100% | ||
| DSI |
|
0 | 0.2193 | -100% |
|
|
| Average dividend growth |
|
0 | 0.4414 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4968 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5468 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
8286.96 | -56.89 | -14666.64% | ||
| Growth impulse Ebitda in 5 years |
|
99.83 | -54.68 | -282.57% | ||
| Growth impulse Net Income in 5 years |
|
107.33 | -58.33 | -284% | ||
| Growth impulse FCF in 5 years |
|
-118.9 | -49.48 | 140.3% | ||
| Growth impulse EPS in 5 years |
|
-41.61 | -32.41 | 28.39% |
IP Score
3.46/10
